Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRAL | NBTX | SRPT | ||
| Company | Grail Inc | Nanobiotix S.A. ADR | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 50.00 | 40.56 | 17.63 | ||
| High | 51.15 | 40.99 | 18.20 | ||
| Low | 47.94 | 37.92 | 17.42 | ||
| Latest | 48.67 | 38.65 | 17.66 | ||
| Change | -1.15 | -1.48 | +0.02 | ||
| % Change | -2.31% | -3.69% | +0.11% | ||
| Volume | 849,510 | 98,637 | 2,727,515 | ||
| 20-Day Average Volume | 2,208,000 | 52,717 | 2,327,736 | ||
| Previous Close | 49.82 | 40.13 | 17.64 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 68.35 | 29.21 | 17.59 | ||
| 20-Day Raw Stochastic | 10.62% | 83.06% | 57.32% | ||
| 20-Day Relative Strength | 33.87 | 70.22 | 45.45 | ||
| Weighted Alpha | +85.93 | +795.01 | -52.26 | ||
| Today's Opinion | 40% Sell | 100% Buy | 88% Sell | ||
| Previous Opinion | 40% Sell | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 88% Buy | 40% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.75% since 03/03/26 | +26.39% since 03/03/26 | +11.28% since 03/03/26 | ||
| Low | 46.62 on 03/09/26 | 32.63 on 03/06/26 | 15.52 on 03/06/26 | ||
| High | 56.15 on 03/04/26 | 41.89 on 03/09/26 | 18.20 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | -53.06% since 02/10/26 | +46.24% since 02/10/26 | -3.66% since 02/10/26 | ||
| Low | 41.50 on 02/23/26 | 22.76 on 02/11/26 | 15.52 on 03/06/26 | ||
| High | 109.04 on 02/18/26 | 41.89 on 03/09/26 | 19.25 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | -48.73% since 12/10/25 | +71.47% since 12/10/25 | -20.45% since 12/10/25 | ||
| Low | 41.50 on 02/23/26 | 19.61 on 01/12/26 | 15.52 on 03/06/26 | ||
| High | 118.84 on 01/22/26 | 41.89 on 03/09/26 | 24.68 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | +37.41% since 09/10/25 | +313.36% since 09/10/25 | +2.56% since 09/10/25 | ||
| Low | 35.43 on 09/11/25 | 9.32 on 09/15/25 | 15.08 on 11/04/25 | ||
| High | 118.84 on 01/22/26 | 41.89 on 03/09/26 | 25.32 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,942,083 | 1,942,332 | 1,852,024 | ||
| Shares Outstanding, K | 38,982 | 48,401 | 104,990 | ||
| Annual Sales | 147,170,000 | -7,780,000 | 2,198,240,000 | ||
| Annual Net Income | -408,350,000 | -73,730,000 | -713,410,000 | ||
| Last Quarter Sales | 43,600,000 | N/A | 442,930,000 | ||
| Last Quarter Net Income | -99,180,000 | N/A | -282,850,000 | ||
| 60-Month Beta | 5.21 | 0.62 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.46 on 11/12/25 | N/A | -3.58 on 02/25/26 | ||
| Latest Earnings Date | 05/12/26 | 04/01/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||